# Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis

> **NCT02475304** · PHASE2 · WITHDRAWN · sponsor: **Skane University Hospital**

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **DRUG:** FP187
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02475304
- **Lead sponsor:** Skane University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-10
- **Final completion:** 2017-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Difficulties to enrol patients
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475304, "Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02475304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*